NO894083D0 - Framsoeytiske blandinger for behandling av adrenoleukodystrophy. - Google Patents

Framsoeytiske blandinger for behandling av adrenoleukodystrophy.

Info

Publication number
NO894083D0
NO894083D0 NO894083A NO894083A NO894083D0 NO 894083 D0 NO894083 D0 NO 894083D0 NO 894083 A NO894083 A NO 894083A NO 894083 A NO894083 A NO 894083A NO 894083 D0 NO894083 D0 NO 894083D0
Authority
NO
Norway
Prior art keywords
pct
treatment
prosoeytic
addrenoleucodystrophy
mixtures
Prior art date
Application number
NO894083A
Other languages
English (en)
Norwegian (no)
Other versions
NO894083L (no
Inventor
Donald Suddaby
Keith Coupland
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO894083(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croda Int Plc filed Critical Croda Int Plc
Publication of NO894083L publication Critical patent/NO894083L/no
Publication of NO894083D0 publication Critical patent/NO894083D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C07C67/54—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
NO894083A 1988-02-23 1989-10-12 Framsoeytiske blandinger for behandling av adrenoleukodystrophy. NO894083D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888804188A GB8804188D0 (en) 1988-02-23 1988-02-23 Pharmaceutical compositions
PCT/GB1988/000373 WO1989008095A1 (en) 1988-02-23 1988-05-13 Pharmaceutical compositions for treating adrenoleukodystrophy

Publications (2)

Publication Number Publication Date
NO894083L NO894083L (no) 1989-10-12
NO894083D0 true NO894083D0 (no) 1989-10-12

Family

ID=10632210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894083A NO894083D0 (no) 1988-02-23 1989-10-12 Framsoeytiske blandinger for behandling av adrenoleukodystrophy.

Country Status (10)

Country Link
US (1) US5331009A (de)
EP (1) EP0360821B1 (de)
JP (1) JPH0667869B2 (de)
AT (1) ATE86965T1 (de)
CA (1) CA1308028C (de)
DE (1) DE3879489T2 (de)
DK (1) DK521389A (de)
GB (1) GB8804188D0 (de)
NO (1) NO894083D0 (de)
WO (1) WO1989008095A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
AU6269799A (en) 1998-09-28 2000-04-17 Johns Hopkins University, The Adrenoleukodystrophy treatments and drug screening
JP2001278786A (ja) * 2000-03-29 2001-10-10 Morinaga Milk Ind Co Ltd 高尿酸性疾患予防治療剤
ES2978914T3 (es) 2014-07-02 2024-09-23 Nissui Corp Método para producir ácidos grasos libres insaturados monovalentes derivados de productos marinos o ésteres de alcohol inferior de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
US4377526A (en) * 1981-05-15 1983-03-22 Nippon Suisan Kaisha, Ltd. Method of purifying eicosapentaenoic acid and its esters
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis

Also Published As

Publication number Publication date
EP0360821A1 (de) 1990-04-04
DE3879489T2 (de) 1993-06-24
NO894083L (no) 1989-10-12
ATE86965T1 (de) 1993-04-15
CA1308028C (en) 1992-09-29
DK521389D0 (da) 1989-10-20
DE3879489D1 (de) 1993-04-22
JPH0667869B2 (ja) 1994-08-31
JPH02503792A (ja) 1990-11-08
GB8804188D0 (en) 1988-03-23
US5331009A (en) 1994-07-19
EP0360821B1 (de) 1993-03-17
DK521389A (da) 1989-12-15
WO1989008095A1 (en) 1989-09-08

Similar Documents

Publication Publication Date Title
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
GR3019315T3 (en) Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
AU1537095A (en) Therapeutic agents containing thyroid hormones
MY101791A (en) New benzimidazole derivatives
DE69012985D1 (de) Verkapselung von mischgetrockneter sucralose mit polyvinylacetat zur verwendung in kaugummi.
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
GB9424766D0 (en) Pharmaceutical composition
ATE82120T1 (de) Kalziumzusaetze.
ATE57188T1 (de) Pharmazeutische peptide, ihre herstellung und verwendung sowie zwischenprodukte.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE3880587D1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
NO894083D0 (no) Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
GR890100563A (el) Προαγωγη της αναπτυξεως χοιρων.
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
CA2086754A1 (en) Treatment of Human Lactation Failure
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
JPS5626819A (en) Preventive for hypoimmunity
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
ATE73326T1 (de) Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.